[RCKT] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[RCKT] Rocket Pharmaceuticals, Inc.
Announcement Date
09-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -28.14%
YoY- 80.11%
Quarter Report
RCKT's Result
RCKT's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -29,080 -19,284 -16,089 -7,395 -11,128 -55,961 -2,388 51.62%
Tax 518 1,466 1,137 219 120 192 0 -
NP -29,080 -19,284 -16,089 -7,395 -11,128 -55,961 -2,388 51.62%
Tax Rate - - - - - - - -
Total Cost 29,080 19,284 16,089 7,395 11,128 55,961 2,388 51.62%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.53 -0.38 -0.40 -1.09 -1.65 -9.92 -1.14 -11.97%
EPS Diluted -0.53 -0.38 -0.40 -1.09 -1.65 -9.92 -1.14 -11.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.